Announced
Synova Capital to invest in Preventx.
Synopsis
Synova Capital agreed to invest in Preventx, provider of online-led sexual health testing and diagnostic services and the only UK company with a fully integrated laboratory model. Financial terms were not disclosed. This is the first investment for Synova's latest vehicle. The GP held a first and final close for Synova IV on its £365m ($463m) hard-cap in June.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.